AquaLumen Filtration Procedure for Glaucoma
What You Need to Know Before You Apply
What is the purpose of this trial?
The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How does the AquaLumen treatment for glaucoma differ from other treatments?
The AquaLumen treatment for glaucoma is unique because it involves a filtration procedure that may use a novel implant or device to regulate eye pressure, unlike traditional surgeries like trabeculectomy or drug therapies. This approach might offer a new way to manage intraocular pressure by potentially bypassing obstructions in the eye's drainage system.12345
What data supports the effectiveness of the AquaLumen treatment for glaucoma?
Are You a Good Fit for This Trial?
This clinical trial is for individuals with a condition called Open Angle Glaucoma, which increases pressure inside the eye. Participants should be those who require treatment to lower this pressure and are willing to undergo surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Treatment
Participants undergo a surgical procedure intended to reduce intra-ocular pressure (IOP)
Follow-up
Participants are monitored for safety and effectiveness after the surgical procedure
What Are the Treatments Tested in This Trial?
Interventions
- AquaLumen
Find a Clinic Near You
Who Is Running the Clinical Trial?
PLU Ophthalmic
Lead Sponsor